Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-725,823
Closed -$10.7M 6116
2025
Q3
$10.7M Sell
725,823
-236,651
-25% -$2.41M ﹤0.01% 2329
2025
Q2
$9.45M Buy
962,474
+510,020
+113% +$4.22M ﹤0.01% 2320
2025
Q1
$3.29M Sell
452,454
-255,742
-36% -$2.24M ﹤0.01% 3291
2024
Q4
$5.54M Buy
708,196
+326,215
+85% +$2.69M ﹤0.01% 2729
2024
Q3
$2.83M Sell
381,981
-628,371
-62% -$5.28M ﹤0.01% 3371
2024
Q2
$8.09M Sell
1,010,352
-76,845
-7% -$686K ﹤0.01% 2281
2024
Q1
$12.7M Buy
1,087,197
+528,312
+95% +$5.85M 0.01% 1975
2023
Q4
$6.24M Buy
558,885
+453,032
+428% +$4.16M ﹤0.01% 2599
2023
Q3
$1.63M Sell
105,853
-214,297
-67% -$3.6M ﹤0.01% 3751
2023
Q2
$6.07M Sell
320,150
-1,223,497
-79% -$21.5M ﹤0.01% 2486
2023
Q1
$23.5M Sell
1,543,647
-12,586
-0.8% -$164K 0.01% 1222
2022
Q4
$19.8M Buy
1,556,233
+706,686
+83% +$6.36M 0.01% 1454
2022
Q3
$4.92M Buy
849,547
+700,425
+470% +$3.08M ﹤0.01% 2901
2022
Q2
$480K Buy
149,122
+80,905
+119% +$244K ﹤0.01% 4984
2022
Q1
$257K Buy
+68,217
New +$439K ﹤0.01% 5683
2021
Q2
Sell
-104,013
Closed -$2.46M 6660
2021
Q1
$2.46M Sell
104,013
-9,686
-9% -$224K ﹤0.01% 3338
2020
Q4
$2.77M Sell
113,699
-4,844
-4% -$124K ﹤0.01% 2968
2020
Q3
$3.04K Buy
118,543
+96,840
+446% +$3.07M ﹤0.01% 2264
2020
Q2
$433K Buy
+21,703
New +$527K ﹤0.01% 3489

Other funds holding ETNB

Millennium Management's ETNB Position: Q4 2025 in Review

Millennium Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 725,823 shares — an estimated $10.7M sold.

Millennium Management first reported a position in ETNB in Q2 2020 and held it in 19 quarters. The position peaked at $23.5M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Millennium Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 725,823 89bio shares in Q4 2025, an estimated $10.7M.
  • Millennium Management first reported a position in 89bio in Q2 2020 and held it in 19 quarters.
  • Millennium Management's 89bio position peaked at $23.5M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.